Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 584 results for "erbitux"

Merck KGaA leans heavily on oncology portfolio to stem decline in biopharma revenue growth
DataMonitor HealthCare

Merck KGaA leans heavily on oncology portfolio to stem decline...

Merck KGaA is undergoing a transition in the biopharma business as key products Rebif (interferon beta-1a) and Erbitux (cetuximab) experience significant sales declines over the forecast period. Merck KGaA will attempt to combat these declines with ... DataMonitor HealthCare, 1 month ago
[x]  

11 images for erbitux

Pharmafile, 3 weeks ago
Nasdaq, 3 weeks ago
European Pharmaceutical Manufacturer, 1 month ago
Nasdaq, 3 months ago
Northern Public Radio, 4 months ago
Medagadget.com, 4 months ago
Medagadget.com, 4 months ago
Medagadget.com, 5 months ago
OncLive, 5 months ago
OncLive, 5 months ago
Pharmafile

Merck Provides Results of Pivotal Study That Confirms Addition of Erbitux to FOLFOX Significantly Improves Outcomes

Posted Date: 7/11/2016 Merck presented data at the ESMO 18th World Congress on Gastrointestinal Cancer (WCGC) from the pivotal Phase III TAILOR study in patients from China, the first prospective trial to evaluate an anti-EGFR antibody in the ...
 Drug Development & Delivery2 weeks ago Cetuximab Plus FOLFOX-4 Chemo Improved Survival in RAS Wild-Type CRC  Targeted Oncology2 weeks ago TAILOR study shows treatment with Erbitux plus FOLFOX improves survival in RAS wild-type mCRC patients  News-Medical.Net3 weeks ago Merck says its Erbitux in combination with Folfox improves outcomes in colorectal cancer  Pharmafile3 weeks ago
[x]  
Nasdaq

Merck reports positive pivotal Phase III TAILOR study results of Erbitux and FOLFOX combination for mCRC

Merck has reported a positive outcome of pivotal Phase III TAILOR study of the combination of Erbitux (cetuximab) and FOLFOX to treat RAS wild-type, metastatic colorectal cancer (mCRC). Erbitux is an active IG1 monoclonal, antibody targeting, ...
 Drug Development Technology3 weeks ago Merck: Erbitux Plus FOLFOX Shows Response Rate Of 61.1% In Phase III Study  Nasdaq3 weeks ago

Global Erbitux Industry 2016 Market Overview, Size, Share, Trends, Analysis And Technology

The report on the global Erbitux market is aimed at informing stakeholders about the prevailing market dynamics. It informs them about the impact of the strategies adopted by the leading enterprises on the market. The impact of the latest ...
 MyNewsDesk3 weeks ago Global Personalized Medicine Market Analysis & Trends - Industry Forecast to 2025  Research and Markets1 month ago

Bristol-Myers Squibb (BMY) Giovanni Caforio on Q2 2016 Results - Earnings Call Transcript

Bristol-Myers Squibb Co. (NYSE: BMY ) Q2 2016 Earnings Call July 28, 2016 10:30 am ET Executives John E. Elicker - Senior VP-Public Affairs & Investor Relations Giovanni Caforio - Chief Executive Officer & Director Charles A.
 Seeking Alpha2 hours ago Bristol-Myers Squibb Lifts FY16 Earnings View As Q2 Results Top Estimates  Nasdaq13 hours ago

Bristol-Myers Squibb Reports Second Quarter Financial Results

Bristol-Myers Squibb Company (NYSE:BMY) today reported results for the second quarter of 2016, which were highlighted by strong sales, key regulatory and clinical milestones in Immuno-Oncology and business development transactions that strengthened ...
 Wallstreet Online14 hours ago BMS names Fouad Namouni as new oncology development head  Pharmafile2 days ago Bristol-Myers Squibb Appoints Fouad Namouni, M.D., Oncology Development Head  Wallstreet Online3 days ago BRISTOL MYERS SQUIBB : Appoints Fouad Namouni, M.D., Oncology Development Head  4 Traders3 days ago
[x]  
Nasdaq

Bristol-Myers (BMY) Beats on Q2 Earnings, Lifts Outlook

Bristol-Myers Squibb Company 's BMY second-quarter 2016 earnings of 69 cents per share beat the Zacks Consensus Estimate of 67 cents and increased 30% from the year-ago figure. Total revenue of $4.87 billion was also above the Zacks Consensus ...
 Nasdaq9 hours ago
[x]  
pharmaphorum

Ricks to succeed Lechleiter as Lilly chief

Eli Lilly's chief executive, chairman and president John Lechleiter is to step down in December, and will be replaced David Ricks, who currently leads the company's bio-medicines division. Lechleiter (pictured) will continue to serve on Lilly's ...
 pharmaphorum1 day ago Eli Lilly & Co. (LLY) John C. Lechleiter on Q2 2016 Results - Earnings Call Transcript  Seeking Alpha2 days ago Why Eli Lilly Earnings Are So Dynamic  24/7 Wall St2 days ago Eli Lilly (LLY) May Beat Q2 Earnings: Will the Stock Gain?  Zacks.com1 week ago
[x]  

Gradalis Inc. Appoints Chief Medical Officer

/PRNewswire/ -- Gradalis, Inc. today announced the appointment of Dr. Martin Birkhofer as Sr. Vice President and Chief Medical Officer. Dr. Birkhofer will provide strategic oversight of Gradalis' clinical development pipeline and will also be ...
 BioSpace2 days ago Gradalis, Inc. : Appoints Martin J. Birkhofer, M.D. Chief Medical Officer  4 Traders2 days ago Gradalis Inc Appoints Martin J Birkhofer MD Chief Medical Officer  Pharma Focus Asia1 day ago Gradalis Appoints Martin J. Birkhofer, M.D. Chief Medical Officer  FirstWord Pharma2 days ago
[x]  
Benzinga.com

Lilly Reports Second-Quarter 2016 Results, Provides Financial Expectations Through the Remainder of the Decade

- Revenue increased 9 percent, driven by 10 percent pharmaceutical volume growth coming primarily from recent product launches. - Second-quarter 2016 earnings per share (EPS) were $0.71 (reported), or $0.86 (non-GAAP). - The company confirms 2016 ...
 Benzinga.com2 days ago Eli Lilly Reports Second-Quarter 2016 Results, Provides Financial Expectations Through The Remainder Of The Decade  BioSpace2 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - erbitux
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less